Trial in progress: phase 1b dose-finding study of axitinib plus pembrolizumab for first-line treatment of advanced renal cell carcinoma (RCC)T. K. Choueiri,E. R. Plimack,S. Gupta,D. Cho,T. E. Hutson,I. Puzanov,S. George,T. Olencki, U. Vaishampayan,D. Chakrabarti,Y. K. Pithavala,J. A. Williams,B. Rosbrook,J. C. Tarazi,M. B. AtkinsBJU INTERNATIONAL(2014)引用 1|浏览19暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要